During the Research Phase, NUCOAT researchers will develop and validate physical function “performance outcome” and “patient reported outcome” assessments.
During the research phase we will:
- Continue to research sarcopenia in older adults and three rare disorders in further detail
- Conduct in-depth patient interviews for analysis on physical function impacts
- Test a draft Clinical Outcome Assessment in a cognitive interview study, which will eventually be tested against current, standard assessments
- Consult expert panels (the Stakeholder Engagement Group and Clinical Expert Panel) for input on development and validation of physical function assessments
Once the assessments are finalized, the NUCOAT team will work with the United States Food and Drug Administration (FDA) to distribute the assessments to interested groups of patients, care partners, industry professionals, and policy makers.. The assessments and information about the assessments will be available through HealthMeasures.net.